Vestcor Inc Purchases 9,006 Shares of HCA Healthcare, Inc. $HCA

Vestcor Inc increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 65.3% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 22,795 shares of the company’s stock after purchasing an additional 9,006 shares during the quarter. Vestcor Inc’s holdings in HCA Healthcare were worth $9,715,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Sovran Advisors LLC boosted its position in shares of HCA Healthcare by 1.0% in the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock valued at $1,063,000 after acquiring an additional 22 shares during the period. Centerpoint Advisors LLC raised its stake in HCA Healthcare by 11.0% in the 3rd quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock worth $95,000 after purchasing an additional 22 shares in the last quarter. Cary Street Partners Financial LLC grew its position in shares of HCA Healthcare by 3.9% during the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock worth $251,000 after purchasing an additional 22 shares in the last quarter. Angeles Wealth Management LLC raised its position in shares of HCA Healthcare by 2.4% in the third quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock valued at $432,000 after buying an additional 24 shares in the last quarter. Finally, Hemington Wealth Management grew its position in HCA Healthcare by 11.0% during the third quarter. Hemington Wealth Management now owns 253 shares of the company’s stock worth $107,000 after buying an additional 25 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on HCA. Oppenheimer upped their target price on HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Argus boosted their price target on HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a research note on Friday, February 6th. KeyCorp set a $503.00 target price on shares of HCA Healthcare in a report on Wednesday, January 28th. Morgan Stanley downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price target for the company. in a report on Monday, December 15th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $534.50.

HCA Healthcare Trading Up 2.5%

HCA stock opened at $545.88 on Tuesday. The stock has a market capitalization of $122.07 billion, a P/E ratio of 19.23, a price-to-earnings-growth ratio of 1.64 and a beta of 1.34. The firm has a 50-day moving average price of $501.78 and a 200-day moving average price of $466.79. HCA Healthcare, Inc. has a 12 month low of $310.18 and a 12 month high of $552.90.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period in the prior year, the company earned $6.22 EPS. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio is presently 10.15%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at $6,171,357.94. The trade was a 40.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president directly owned 44,379 shares of the company’s stock, valued at $22,411,395. The trade was a 8.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 over the last three months. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.